Canertinib dihydrochloride(CAS: 289499-45-2)

Canertinib dihydrochloride is a chemotherapy agent with the chemical formula C21H16N4O2⋅2HCl. It is characterized by its potent antitumor activity, particularly against certain types of cancer cells.

Canertinib dihydrochloride is primarily used in the treatment of non-small cell lung cancer and other solid tumors. It is administered orally and is part of the therapeutic regimen for advanced or metastatic cancers.

Canertinib dihydrochloride can be safe when used under the guidance of a healthcare professional. However, it is important to follow all safety precautions, including monitoring for side effects such as nausea, vomiting, and skin changes. Protective measures include avoiding contact with eyes and skin, and proper disposal of unused medication.

Canertinib dihydrochloride should be stored in a tightly closed container at room temperature (15-30°C) away from direct sunlight and moisture. It is crucial to keep it out of reach of children and pets and follow local regulations for the disposal of unused medication and packaging.